查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417709

生物製程验证市场报告：2030 年趋势、预测与竞争分析

Bioprocess Validation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

生物製程验证的趋势和预测

2024年至2030年，全球生物製程验证市场将以9.5%的复合年增长率成长。该市场的主要驱动因素是确保安全和品质标准的日益严格的法规、生物製药行业需求的增加以及对外包生物製程验证的兴趣日益浓厚。全球生物製程验证市场的未来充满希望，製药、生物技术、合约研究和受託製造厂商市场充满机会。

生物製程验证市场洞察

Lucintel 预测，由于生物製药製造商增加了测试服务外包，可提取性/浸出性测试服务在预测期内仍将是最大的细分市场。

由于生物製药产量的增加，製药公司仍将是市场上最大的部分。

由于生物製程验证服务外包趋势的上升以及该地区政府的积极倡议，预计亚太地区在预测期内将出现最高成长。

常问问题

Q1.市场成长预测如何？

A1. 从 2024 年到 2030 年，全球生物製程验证市场预计将以 9.5% 的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 该市场的主要驱动力是确保安全和品质标准的日益严格的法规、生物製药行业不断增长的需求以及对外包生物製程验证的兴趣日益增长。

Q3.市场的主要细分市场有哪些？

A3. 生物製程验证市场的未来对于製药公司、生技公司以及合约开发和受託製造厂商市场来说是充满希望的。

Q4.市场上主要企业有哪些？

A4.主要的生物製程验证公司如下。

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计，由于生物製药製造商增加了测试服务外包，可提取性/浸出性测试服务在预测期内仍将是最大的细分市场。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于生物製程验证服务外包的趋势不断增加以及该地区政府的积极倡议，预计亚太地区在预测期内将出现最高的增长。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球生物製程验证市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球生物製程验证市场趋势（2018-2023）与预测（2024-2030）
  • 按测试类型分類的全球生物工艺验证市场
    • 萃取物/可浸出物测试服务
    • 微生物检测服务
    • 完整性测试服务
    • 其他的
  • 按工艺组件分類的全球生物工艺验证市场
    • 滤芯
    • 媒体容器和媒体袋
    • 冷冻和解冻加工袋
    • 混合系统
    • 反应器
    • 输送系统
    • 其他的
  • 按最终用途分類的全球生物製程验证市场
    • 製药公司
    • 生技公司
    • 合约开发和製造组织
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球生物工艺验证市场
  • 北美生物製程验证市场
  • 欧洲生物工艺验证市场
  • 亚太生物製程验证市场
  • 其他地区的生物製程验证市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按测试类型分類的全球生物工艺验证市场成长机会
    • 按工艺组件分類的全球生物工艺验证市场成长机会
    • 按最终用途分類的全球生物工艺验证市场成长机会
    • 按地区分類的全球生物工艺验证市场成长机会
  • 全球生物製程验证市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球生物工艺验证市场的能力
    • 全球生物工艺验证市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall
简介目录

Bioprocess Validation Trends and Forecast

The future of the global bioprocess validation market looks promising with opportunities in the pharmaceutical company, biotechnology company, and contract development & manufacturing organization markets. The global bioprocess validation market grow with a CAGR of 9.5% from 2024 to 2030. The major drivers for this market are increasing strict rules to ensure safety and quality standards, growing demand from biopharmaceutical industry, and rising interest in outsourcing the validation of bioprocesses.

A more than 150-page report is developed to help in your business decisions.

Bioprocess Validation by Segment

The study includes a forecast for the global bioprocess validation by test type, process component, end use, and region.

Bioprocess Validation Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

  • Extractables/Leachables Testing Services
  • Microbiological Testing Services
  • Integrity Testing Services
  • Others

Bioprocess Validation Market by Process Component [Shipment Analysis by Value from 2018 to 2030]:

  • Filter Elements
  • Media Containers and Bags
  • Freezing and Thawing Process Bags
  • Mixing Systems
  • Bioreactors
  • Transfer Systems
  • Others

Bioprocess Validation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Others

Bioprocess Validation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bioprocess Validation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bioprocess validation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bioprocess validation companies profiled in this report include-

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall

Bioprocess Validation Market Insights

Lucintel forecasts that extractable/leachable testing service will remain the largest segment over the forecast period due to rising outsourcing of testing services by biopharmaceutical manufacturers.

Within this market, pharmaceutical company will remain the largest segment due to rising production levels of biopharmaceuticals.

APAC is expected to witness highest growth over the forecast period due to growing trend toward outsourcing bioprocess validation services and favourable government intiatives in the region.

Features of the Global Bioprocess Validation Market

Market Size Estimates: Bioprocess validation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Bioprocess validation market size by test type, process component, end use, and region in terms of value ($B).

Regional Analysis: Bioprocess validation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, process components, end uses, and regions for the bioprocess validation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bioprocess validation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for bioprocess validation market?

Answer: The global bioprocess validation market is expected to grow with a CAGR of 9.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the bioprocess validation market?

Answer: The major drivers for this market are increasing strict rules to ensure safety and quality standards, growing demand from biopharmaceutical industry, and rising interest in outsourcing the validation of bioprocesses.

Q3. What are the major segments for bioprocess validation market?

Answer: The future of the bioprocess validation market looks promising with opportunities in the pharmaceutical company, biotechnology company, and contract development & manufacturing organization markets.

Q4. Who are the key bioprocess validation market companies?

Answer: Some of the key bioprocess validation companies are as follows.

  • Merck
  • SGS
  • Eurofins Scientific
  • Sartorius
  • Pall

Q5. Which bioprocess validation market segment will be the largest in future?

Answer: Lucintel forecasts that extractable/leachable testing service will remain the largest segment over the forecast period due to rising outsourcing of testing services by biopharmaceutical manufacturers.

Q6. In bioprocess validation market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing trend toward outsourcing bioprocess validation services and favourable government intiatives in the region.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bioprocess validation market by test type (extractables/leachables testing services, microbiological testing services, integrity testing services, and others), process component (filter elements, media containers and bags, freezing and thawing process bags, mixing systems, bioreactors, transfer systems, and others), end use (pharmaceutical companies, biotechnology companies, contract development & manufacturing organizations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bioprocess Validation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bioprocess Validation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bioprocess Validation Market by Test Type
    • 3.3.1: Extractables/Leachables Testing Services
    • 3.3.2: Microbiological Testing Services
    • 3.3.3: Integrity Testing Services
    • 3.3.4: Others
  • 3.4: Global Bioprocess Validation Market by Process Component
    • 3.4.1: Filter Elements
    • 3.4.2: Media Containers and Bags
    • 3.4.3: Freezing and Thawing Process Bags
    • 3.4.4: Mixing Systems
    • 3.4.5: Bioreactors
    • 3.4.6: Transfer Systems
    • 3.4.7: Others
  • 3.5: Global Bioprocess Validation Market by End Use
    • 3.5.1: Pharmaceutical Companies
    • 3.5.2: Biotechnology Companies
    • 3.5.3: Contract Development & Manufacturing Organizations
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bioprocess Validation Market by Region
  • 4.2: North American Bioprocess Validation Market
    • 4.2.2: North American Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others
  • 4.3: European Bioprocess Validation Market
    • 4.3.1: European Bioprocess Validation Market by Test Type: Extractables/Leachables Testing Services, Microbiological Testing Services, Integrity Testing Services, and Others
    • 4.3.2: European Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others
  • 4.4: APAC Bioprocess Validation Market
    • 4.4.1: APAC Bioprocess Validation Market by Test Type: Extractables/Leachables Testing Services, Microbiological Testing Services, Integrity Testing Services, and Others
    • 4.4.2: APAC Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others
  • 4.5: ROW Bioprocess Validation Market
    • 4.5.1: ROW Bioprocess Validation Market by Test Type: Extractables/Leachables Testing Services, Microbiological Testing Services, Integrity Testing Services, and Others
    • 4.5.2: ROW Bioprocess Validation Market by End Use: Pharmaceutical Companies, Biotechnology Companies, Contract Development & Manufacturing Organizations, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bioprocess Validation Market by Test Type
    • 6.1.2: Growth Opportunities for the Global Bioprocess Validation Market by Process Component
    • 6.1.3: Growth Opportunities for the Global Bioprocess Validation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bioprocess Validation Market by Region
  • 6.2: Emerging Trends in the Global Bioprocess Validation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bioprocess Validation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bioprocess Validation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: SGS
  • 7.3: Eurofins Scientific
  • 7.4: Sartorius
  • 7.5: Pall